Drug details

Khedezla (desvenlafaxine extended-release tablets)

type of Antidepressants, SNRIs

Khedezla (desvenlafaxine) is a type of antidepressant called a serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder (MDD).

This drug may have the following side effects:

• nausea,
• headache,
• dizziness,
• blurred vision,
• vomiting,
• diarrhea,
• constipation,
• loss of appetite,
• nervousness,
• weight loss,
• chills,
• dry mouth,
• trouble sleeping (insomnia),
• drowsiness,
• anxiety,
• increased sweating,
• ringing in the ears,
• fatigue,
• irritability,
• decreased sex drive,
• changes in taste, and
• tremors, 
• dilated pupils,
• strange dreams,
• hot flashes.
• feeling jittery,
• sleepiness,
• spinning sensation (vertigo),
• delayed orgasm and ejaculation,
• elevated blood pressure,
• difficulty paying attention,
• urinary hesitancy,
• yawning,

The following drugs are related to Khedezla, either as a replacement or used together:

• Abilify (aripiprazole)
• Wellbutrin (bupropion hcl)
• Wellbutrin XL (bupropion hydrochloride extended-release)
• Wellbutrin SR (bupropion hydrochloride sustained-release)
• Celexa (citalopram hydrobromide)
• Cymbalta (duloxetine hcl)
• Desyrel (trazodone hydrochloride)
• Effexor (venlafaxine hydrochloride)
• Effexor XR (venlafaxine hydrochloride extended-release)
• Prozac (fluoxetine hcl)
• Zoloft (sertraline hcl)